SAN DIEGO, January 30, 2025--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious ...
If you're interested in exploring more stocks under $100 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Do you think that you can’t start ...
At close: February 3 at 3:00:00 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback